Abstract
Salivary IgA antibody to poliovirus and tetanus toxoid was measured in whole salivas of 151 children between 2 and 48 months of age from North America and from Scandinavia. Children from urban and suburban populations in the greater Boston, MA, area receive both oral poliovaccine and a parenteral injection with tetanus toxoid (TT), initially at approximately 2 months of age. Children from Göteborg, Sweden, initially receive parenteral injections of TT at 2 months of age and parenteral injections of killed polio vaccine initially at 9 to 10 months of age. Twenty-six percent of the Boston subjects who were less than 12 months old had detectable salivary IgA antibody to poliovirus after oral immunization. In contrast, within the first year after parenteral immunization with killed poliovirus, the Swedish group had detectable salivary antibody in 9% (1 of 13) of the subjects. Forty to 65% of the children in the older Boston-area age groups had positive salivary IgA antibody levels to this antigen. No differences were seen in salivary IgA antibody to TT among the three populations. By 36 months of age at least 50% of all populations had detectable salivary antibody to TT. The ratio of enzyme-linked immunosorbent assay (ELISA) activity using rabbit anti-human secretory component versus rabbit anti-human alpha chain was significantly higher in subjects less than 12 months of age compared with older groups. This suggested either that free secretory component was binding to tetanus toxoid or that secretory antibody of isotypes other than IgA was present in these youngest subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Haworth JC, Dilling L: Concentration of γ A globulin in serum, saliva, and nasopharyngeal secretions of infants and children. J Lab Clin Med 67:922–933, 1966
Berg T: Immunoglobulin levels in infants with low birth weights. Acta Paediat Scand 57:369–376, 1968
Burgio GR, Lanzavecchia A, Plebani A, Jayakar S, Ugazio AG: Ontogeny of secretory immunity: Levels of secretory IgA and natural antibodies in saliva. Pediat Res 14:1111–1114, 1980
Mellander L, Carlsson B, Hanson LA: Appearance of secretory IgM and IgA antibodies toEscherichia coli in saliva during early infancy and childhood. J Pediat 104:564–568, 1984
Ogra SS, Weintraub DI, Ogra PL: Immunologic aspects of human colostrum and milk: Interaction with the intestinal immunity of the neonate. Adv Exp Med Biol 107:97–107, 1978
Hanson L, Ahlstedt A, Andersson B, Carlsson B, Cole M, Cruz J, Dahlgen U, Ericsson TH, Jalil F, Khan SR, Mellander L, Schneerson R, Svanborg-Eden C, Soderstrom T, Wadsworth C: Mucosal immunity. Ann NY Acad Sci 409:1–21, 1983
Ogra PL: Ontogeny of the local immune system. Pediatrics 64(Suppl):765–774, 1979
Engvall E, Perlmann P: Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 109:129–135, 1972
Smith DJ, Ebersole JL, Taubman MA, Gadalla L: Salivary IgA antibody toA. actinomycetemcomitans in a young adult population. J Periodont Res 20:8–11, 1985
Mancini G, Carbonara AO, Heremans JP: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:335–354, 1965
Tomasi T: The Immune System of Secretions. Englewood Cliffs, NJ, Prentice-Hall, 1976, p 20
Palmer EL, Gary GW, Black R, Martin ML: Antiviral activity of colostrum and serum immunoglobulins A and G. J Med Virol 5:123–129, 1980
Ruuskanen O, Viljanen MK, Salmi TT, Lehtonen P, Kouvalainen K, Peltonen T: DTP and DTP-inactivated polio vaccines: Comparison of adverse reactions and IgG, IgM and IgA antibody responses to DTP. Acta Paediat Scand 69:177–182, 1980
Horsfall FL, Tamm I: Viral and Rickettsial Infections of Man. Philadelphia, JB Lijppincott, 1965
Sabin AB, Ward R: The natural history of poliomyelitis. I. Distribution of virus in nervous and non-nervous tissues. J Exp Med 73:771–793, 1941
Wenner HA, Rabe EF: The recovery of virus from regional lymph nodes of fatal human cases of poliomyelitis. Am J Med Sci 222:292–299, 1951
Plotkin SA, Katz M: Administration of oral poliovaccine in relation to time of breast-feeding. J Pediat 84:309, 1974
Ogra PL, Karzon DT: Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of the lower alimentary tract with poliovirus. J Immunol 102:1423–1431, 1969
Svennerholm AM, Hanson LA, Holmgren J, Jalil F, Lindblad BS, Khan SR, Nilsson A, Svennerholm B: Antibody responses to live and killed poliovirus vaccines in the milk of Pakistani and Swedish women. J Infect Dis 143:707–711, 1981
Taubman MA, Genco RJ: Induction and properties of rabbit secretory γ A antibody directed to group A streptococcal carbohydrate. Immunochemistry 8:1137–1155, 1971
Virella G, Fudenberg HH, Kyong KU, Pandey JP, Galbraith RM: A practical method for quantitation of antibody responses to tetanus and diptheria toxoids in normal young children. Z Immun Immunobiol 155:80–86, 1978
Taubman MA, Smith DJ: Effects of local immunization with glucosyltransferase fractions fromStreptococcus mutans on dental caries in rats and hamsters. J Immunol 118:710–720, 1977
Svennerholm AM, Hanson LA, Holmgren J, Lindblad BS, Nilsson B, Quereshi F: Different secretory IgA antibody response to cholera vaccination in Swedish and Pakistani women. Infect Immun 30:427–430, 1980
Brandtzaeg P: Human secretory immunoglobulin M: An immunochemical and immunohistological study. Immunology 29:559–570, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, D.J., Gahnberg, L., Taubman, M.A. et al. Salivary antibody responses to oral and parenteral vaccines in children. J Clin Immunol 6, 43–49 (1986). https://doi.org/10.1007/BF00915363
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915363